Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genomic Characterization of De Novo Metastatic Breast Cancer.

Clinical breast cancer - 1 Feb 2022

Mullangi Samyukta, Vasan Neil

Abstract excerpt

De novo metastatic breast cancer (dnMBC) represents a minority of MBC cases, and as such, its genomics are poorly understood. Characterizing the genomics of dnMBC represents an opportunity to delineate metastatic drivers in the absence of treatment selection. In this review, we first summarize the literature of the genomics of MBC which showed that MBCs have greater mutational burden than early stage, treatment...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to Genetic Testing
Share to Genomics

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Mutation

Share to Neoplasm Metastasis

Share to Neoplasm Recurrence, Local

Share to Prognosis

Source

Open in PubMed Open full text

Identifiers

PMID: 34949553
DOI: 10.1016/j.clbc.2021.11.005
PMCID: PMC8821243

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genomic Characterization of De Novo Metastatic Breast Cancer.PMID 34949553Read ↗

Genomic Characterization of de novo Metastatic Breast Cancer.Semantic proximity Read ↗

The Influence of Cancer Molecular Subtypes and Treatment on the Mutation Spectrum in Metastatic Breast Cancers.Semantic proximity Read ↗

The clinicomolecular landscape of de novo versus relapsed stage IV metastatic breast cancerSemantic proximity Read ↗

New Views into the Genetic Landscape of Metastatic Breast Cancer.Semantic proximity Read ↗

Genomic Alteration in Metastatic Breast Cancer and Its TreatmentSemantic proximity Read ↗

The genomic landscape of metastatic breast cancer highlights changes in mutation and signature frequenciesSemantic proximity Read ↗

The genomic landscape of metastatic breast cancer: Insights from 11,000 tumors.Semantic proximity Read ↗

Genomic Evolution of Breast Cancer Metastasis and Relapse.Semantic proximity Read ↗

Mutational Profile of Metastatic Breast Cancers: A Retrospective Analysis.Semantic proximity Read ↗

Catalog of genetic progression of human cancers: breast cancer.Semantic proximity Read ↗

Multiplatform Analysis of Primary and Metastatic Breast Tumors from the AURORA US Network identifies microenvironment and epigenetics drivers of metastasisSemantic proximity Read ↗

Molecular features of untreated breast cancer and initial metastatic event inform clinical decision-making and predict outcome: long-term results of ESOPE, a single-arm prospective multicenter study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.